Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat

Our previous kinetic analyses have shown that rat organic anion transporter 1 (rOat1; Slc22a6) and rOat3 (Slc22a8) are responsible for the renal uptake of p-aminohippurate and pravastatin, respectively. In this study, their contribution to the renal uptake of organic anions and nucleoside derivatives was examined by investigating the uptake by rOat1- and rOat3-expressing cells and kidney slices. Transfection of rOat1 resulted in an increase of the uptake of temocaprilat (Km = 0.56 μM), 2,4-dichlorophenoxyacetate (2,4-D; Km = 10 μM), and 3′-azido-3′-deoxythymidine (AZT; Km = 43 μM). rOat3-expressing cells showed significant uptake of temocaprilat (Km = 1.4 μM), estrone sulfate (Km = 5.3 μM), dehydroepiandrosterone sulfate (DHEAS; Km = 12 μM), and benzylpenicillin (PCG; Km = 85 μM). All the test compounds were accumulated in kidney slices in a carrier-mediated manner, although the saturable components of AZT and acyclovir were small. The Km of 2,4-D uptake by kidney slices was comparable with that of rOat1, and the corresponding values of DHEAS and PCG were similar to those of rOat3. The uptake of estrone sulfate and temocapilat by kidney slices consisted of two saturable components, with the Km values of their high-affinity components being similar to those for rOat3 (estrone sulfate), and rOat1 and rOat3 (temocaprilat), respectively. These results suggest that the renal uptake of 2,4-D is mainly accounted for by rOat1 and the uptake of PCG and DHEAS by rOat3, and rOat3 is partly involved in the renal uptake of temocaprilat and estrone sulfate.

[1]  Y. Kanai,et al.  Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.

[2]  C. Goresky,et al.  Enalaprilat handling by the kidney: barrier-limited cell entry. , 1992, The American journal of physiology.

[3]  H. Kusuhara,et al.  Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. , 2002, The Journal of pharmacology and experimental therapeutics.

[4]  S. Choudhuri,et al.  Gender-specific and developmental influences on the expression of rat organic anion transporters. , 2002, The Journal of pharmacology and experimental therapeutics.

[5]  H. Endou,et al.  The multispecific organic anion transporter (OAT) family , 2000, Pflügers Archiv.

[6]  H. Kusuhara,et al.  Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[7]  Y. Kanai,et al.  The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. , 1999, The Journal of pharmacology and experimental therapeutics.

[8]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[9]  D. H. Sweet,et al.  Expression Cloning and Characterization of ROAT1 , 1997, The Journal of Biological Chemistry.

[10]  Yuichi Sugiyama,et al.  Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[11]  E. Babu,et al.  Interaction of human organic anion transporters with various cephalosporin antibiotics. , 2002, European journal of pharmacology.

[12]  Xiao‐ping Yang,et al.  Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. , 2003, American journal of physiology. Renal physiology.

[13]  F. Gennari,et al.  Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B , 1975 .

[14]  J. Kim,et al.  Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.

[15]  Y. Kanai,et al.  Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, American journal of physiology. Renal physiology.

[16]  D. Miller,et al.  Mechanisms mediating renal secretion of organic anions and cations. , 1993, Physiological reviews.

[17]  R. Chambrey,et al.  Polarized Expression of Different Monocarboxylate Transporters in Rat Medullary Thick Limbs of Henle* , 1999, The Journal of Biological Chemistry.

[18]  P. de Miranda,et al.  Metabolic disposition of the acyclovir prodrug valaciclovir in the rat. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[19]  V. Schuster,et al.  Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. , 1999, American journal of physiology. Renal physiology.

[20]  M. Bergeron,et al.  Renal tubular transport of penicillin G and carbenicillin in the rat. , 1975, The Journal of infectious diseases.

[21]  H. Endou,et al.  Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[22]  C. Crespi.  Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research , 1995 .

[23]  H. Yamamoto,et al.  cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter. , 1995, Biochemical and biophysical research communications.

[24]  C. K. Chu,et al.  Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats. , 1989, Journal of pharmaceutical sciences.

[25]  Y. Kanai,et al.  Cloning and Characterization of a Novel Multispecific Organic Anion Transporter * , 1997 .

[26]  A. Enomoto,et al.  Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.

[27]  S. Masuda,et al.  Cellular and molecular aspects of drug transport in the kidney. , 2000, Kidney international.

[28]  F. Russel,et al.  Molecular aspects of renal anionic drug transport. , 2002, Annual review of physiology.

[29]  L. Howell,et al.  The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. , 2001, The Journal of pharmacology and experimental therapeutics.

[30]  Y. Kanai,et al.  Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.

[31]  K. Giacomini,et al.  Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. , 2001, Journal of pharmaceutical sciences.

[32]  D. Beier,et al.  Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice* , 2002, The Journal of Biological Chemistry.

[33]  T. Abe,et al.  Characterization of the Efflux Transport of 17β-Estradiol-d-17β-glucuronide from the Brain across the Blood-Brain Barrier , 2001 .

[34]  H. Endou,et al.  Differential gene expression of organic anion transporters in male and female rats. , 2002, Biochemical and biophysical research communications.

[35]  Y. C. Kim,et al.  Sex-dependent differences in the disposition of 2,4-dichlorophenoxyacetic acid in Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[36]  T Nakagawa,et al.  A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.